BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 11506499)

  • 1. Correlation of vascular endothelial growth factor expression with fibroblast growth factor-8 expression and clinico-pathologic parameters in human prostate cancer.
    West AF; O'Donnell M; Charlton RG; Neal DE; Leung HY
    Br J Cancer; 2001 Aug; 85(4):576-83. PubMed ID: 11506499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between immunohistochemical expression of vascular endothelial growth factor (VEGF), VEGF-expressing neuroendocrine-differentiated tumor cells, and outcome in prostate cancer patients subjected to watchful waiting.
    Borre M; Nerstrøm B; Overgaard J
    Clin Cancer Res; 2000 May; 6(5):1882-90. PubMed ID: 10815911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
    Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
    Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
    Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
    J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vascular endothelial growth factor (VEGF) expression in prostate cancer and benign prostatic hyperplasia.
    Jackson MW; Bentel JM; Tilley WD
    J Urol; 1997 Jun; 157(6):2323-8. PubMed ID: 9146664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Angiogenic cytokines in mesothelioma: a study of VEGF, FGF-1 and -2, and TGF beta expression.
    Kumar-Singh S; Weyler J; Martin MJ; Vermeulen PB; Van Marck E
    J Pathol; 1999 Sep; 189(1):72-8. PubMed ID: 10451491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vascular endothelial growth factor (VEGF) expression in human prostate cancer: in situ and in vitro expression of VEGF by human prostate cancer cells.
    Ferrer FA; Miller LJ; Andrawis RI; Kurtzman SH; Albertsen PC; Laudone VP; Kreutzer DL
    J Urol; 1997 Jun; 157(6):2329-33. PubMed ID: 9146665
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The expression of basic fibroblast growth factor and vascular endothelial growth factor in prostatic adenocarcinoma: correlation with neovascularization.
    Sugamoto T; Tanji N; Sato K; Fujita H; Nishio S; Sakanaka M; Yokoyama M
    Anticancer Res; 2001; 21(1A):77-88. PubMed ID: 11299793
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of vascular endothelial growth factor expression in human ovarian carcinoma.
    Shen GH; Ghazizadeh M; Kawanami O; Shimizu H; Jin E; Araki T; Sugisaki Y
    Br J Cancer; 2000 Jul; 83(2):196-203. PubMed ID: 10901370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An evaluation of the prognostic significance of vascular endothelial growth factor in node positive primary breast carcinoma.
    MacConmara M; O'Hanlon DM; Kiely MJ; Connolly Y; Jeffers M; Keane FB
    Int J Oncol; 2002 Apr; 20(4):717-21. PubMed ID: 11894115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular endothelial growth factor (VEGF) expression is a prognostic factor for radiotherapy outcome in advanced carcinoma of the cervix.
    Loncaster JA; Cooper RA; Logue JP; Davidson SE; Hunter RD; West CM
    Br J Cancer; 2000 Sep; 83(5):620-5. PubMed ID: 10944602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of vascular endothelial growth factor in primary superficial bladder cancer.
    Chow NH; Liu HS; Chan SH; Cheng HL; Tzai TS
    Anticancer Res; 1999; 19(5C):4593-7. PubMed ID: 10650816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibroblast growth factor 17 is over-expressed in human prostate cancer.
    Heer R; Douglas D; Mathers ME; Robson CN; Leung HY
    J Pathol; 2004 Dec; 204(5):578-86. PubMed ID: 15538740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of angiogenetic factors and matrix metalloproteinases upon tumour progression in non-small-cell lung cancer.
    Shou Y; Hirano T; Gong Y; Kato Y; Yoshida K; Ohira T; Ikeda N; Konaka C; Ebihara Y; Zhao F; Kato H
    Br J Cancer; 2001 Nov; 85(11):1706-12. PubMed ID: 11742492
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal growth factor modulates the expression of vascular endothelial growth factor in the human prostate.
    Ravindranath N; Wion D; Brachet P; Djakiew D
    J Androl; 2001; 22(3):432-43. PubMed ID: 11330643
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microautoradiographic quantitation of vascular endothelial growth factor mRNA levels in human prostate specimens containing normal and neoplastic epithelium.
    Woessner RD; Wright PS; Loudy DE; Wallace CD; Montgomery LR; Nestok BR
    Exp Mol Pathol; 1998; 65(1):37-52. PubMed ID: 9613925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of vascular endothelial growth factor correlates with mutant p53 and poor prognosis in human breast cancer.
    Linderholm BK; Lindahl T; Holmberg L; Klaar S; Lennerstrand J; Henriksson R; Bergh J
    Cancer Res; 2001 Mar; 61(5):2256-60. PubMed ID: 11280795
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eukaryotic initiation factor-4E in superficial and muscle invasive bladder cancer and its correlation with vascular endothelial growth factor expression and tumour progression.
    Crew JP; Fuggle S; Bicknell R; Cranston DW; de Benedetti A; Harris AL
    Br J Cancer; 2000 Jan; 82(1):161-6. PubMed ID: 10638984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.